Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.55 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.50 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.50 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.47 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.47 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.46 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.44 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.44 |
| ▸ | RGS12 | O14924 | 1/20 | 0.44 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25152385 | 1.00 | TAAR1 (0.55) | TAAR1GABBR2GABBR1FFAR1PLA2G1B | |
| SCHEMBL1234229 | 1.00 | TAAR1 (0.55) | TAAR1GABBR2GABBR1FFAR1PLA2G1B | |
| SCHEMBL7169658 | 0.89 | FFAR1 (0.55) | FFAR1PLA2G1BATG4BMAPT | |
| SCHEMBL17050186 | 0.88 | TAAR1 (0.55) | TAAR1GABBR2GABBR1PLA2G1BATG4B | |
| SCHEMBL12473262 | 0.87 | GABBR2 (0.57) | GABBR2GABBR1CYP2C19MAPTCYP2D6 | |
| SCHEMBL26724801 | 0.86 | TAAR1 (0.53) | TAAR1PLA2G1BATG4BKCNA3MAPT | |
| SCHEMBL6449839 | 0.86 | GABBR2 (0.48) | TAAR1GABBR2GABBR1FFAR1CYP2C19 | |
| SCHEMBL10247979 | 0.86 | TAAR1 (0.53) | TAAR1PLA2G1BATG4BKCNA3MAPT | |
| SCHEMBL6020157 | 0.84 | GABBR2 (0.52) | TAAR1GABBR2GABBR1FFAR1CYP2C19 | |
| SCHEMBL185647 | 0.84 | TAAR1 (0.57) | TAAR1GABBR2GABBR1PLA2G1BATG4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11634396-B2 | Opioid receptor modulators | EPIODYNE, INC. (US) | 2023-04-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11634396-B2 | Opioid receptor modulators | OPRM1, OPRK1, OPRL1 | TAAR1 173/4885GABBR2 343/4885GABBR1 397/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.